Parry et al. (2013)
Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes |
|---|---|---|
| MZL | 0 | 8 |
| DLBCL | 3 | 1 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 0
New Tier 1, MZL Tier 1, 0
This study, New Tier 2, 8
New Tier 2, MZL Tier 2, 8
All other MZL studies, MZL Tier 1, 42
All other MZL studies, MZL Tier 2, 66
Novel genes reported in this study
Tier 1
| New gene | MZL tier | DLBCL tier |
|---|---|---|
| CREBBP | 2 | 1 |
| FBXO11 | 2 | 1 |
| TRRAP | 2 | 1 |
Tier 2
| New gene | MZL tier | DLBCL tier |
|---|---|---|
| AMOTL1 | 2 | |
| CBFA2T3 | 2 | |
| FAT4 | 2 | 2 |
| PLA2G4D | 2 | |
| USH2A | 2 |
Details
Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis,
Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole
Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients
with Splenic Marginal Zone Lymphoma.” PloS One 8 (12):
e83244. https://doi.org/10.1371/journal.pone.0083244.


